Problems with the Diagnostics of Postural Orthostatic Tachycardia Syndrome. Case Studies
https://doi.org/10.31550/1727-2378-2023-22-2-26-31
Abstract
Objective of the Review: To demonstrate the complexity in diagnosing postural orthostatic tachycardia syndrome.
Key Points. Clinical manifestations of postural orthostatic tachycardia syndrome vary and can have a clinical phenotype that is similar to a number of neurological and somatic conditions.
Conclusion. The case studies presented demonstrate the significance of diagnostic manoeuvres in differentiating this syndrome from other types of impairment of consciousness. An active test in standing position which is easy to conduct can be a diagnostic prompt, if it is verified with a history of typical chronic orthostatic intolerability, postural heart acceleration, and a variety of accompanying complaints.
About the Authors
Yu. R. Gvozdeva
Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
E. A. Kantimirova
Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
D. V. Dmitrenko
Professor V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
References
1. Sheldon R.S., Grubb II B.P., Olshansky B. et al. Heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):41–63. DOI: 10.1016/j.hrthm.2015.03.029
2. Arnold A.C., Ng J., Raj S.R. Postural tachycardia syndrome — diagnosis, physiology, and prognosis. Auton. Neurosci. 2018;215:3–11. DOI: 10.1016/j.autneu.2018.02.005
3. AbdelRazek M., Low Ph., Rocca W., Singer W. Epidemiology of postural tachycardia syndrome (S18.005). Neurology. 2019;92(15Suppl.):S18.005
4. Shibao C., Arzubiaga C., Roberts L.J. et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 2005;45(3):385–390. DOI: 10.1161/01.HYP.0000158259.68614.40
5. Haensch C.A., Lerch H., Schlemmer H. et al. Cardiac neurotransmission imaging with 123I-meta-iodobenzylguanidine in postural tachycardia syndrome. J. Neurol. Neurosurg. Psychiatry. 2010;81(3):339–343. DOI: 10.1136/jnnp.2008.168484
6. Johansson M., Stahberg M., Runold M. et al. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the swedish experience. Am. Coll. Cardiol. Case Rep. 2021;3(4):573–580. DOI: 10.1016/j.jaccas.2021.01.009
7. Miglis M.G., Prieto T., Shaik R. et al. A case report of postural tachycardia syndrome after COVID-19. Clin. Auton. Res. 2020;30(5):449–451. DOI: 10.1007/s10286-020-00727-9
8. Trisvetova E.L. Postural orthostatic tachycardia syndrome as a manifestation of post-COVID-19 syndrome. Rational pharmacotherapy in cardiology. 2022;18(2):200–208. (in Russian). DOI: 10.20996/1819-6446-2022-04-11
9. Chelimsky G., Chelimsky T. The gastrointestinal symptoms present in patients with postural tachycardia syndrome: A review of the literature and overview of treatment. Autonomic Neurosci. 2018;215:70–77. DOI: 10.1016/j.autneu.2018.09.003
10. Raj S.R. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management. Ind. Pacing Electrophysiol. J. 2006;6(2):84–99.
11. Raj V.O., Opie M., Arnold A.C. Cognitive and psychological issues in postural tachycardia syndrome. Auton. Neurosci. 2018;215:45–55. DOI: 10.1016/j.autneu.2018.03.004
12. Strassheim V., Welford J., Ballantine R., Newton J.L. Managing fatigue in postural tachycardia syndrome (POTS): The Newcastle approach. Auton. Neurosci. 2018;215:56–61. DOI: 10.1016/j.autneu.2018.02.003
13. Fu Q., Levine B.D. Exercise and non-pharmacological treatment of pots. Auton. Neurosci. 2018;215:20–27. DOI: 10.1016/j.autneu.2018.07.001
14. Shen W.K., Sheldon R.S., Benditt D.G. et al. 2017 acc/aha/hrs guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology. American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Circulation. 2017;36(5):620–663. DOI: 10.1161/CIR.0000000000000498
15. Kavin L., Nuttall M., Low D.A. et al. A profile of patients with postural tachycardia syndrome and their experience of healthcare in the UK. Br. J. Cardiol. 2016;23:1–6. DOI: 10.5837/bjc.2016.010
16. Nasyrova R.F., Sivakova N.A., Lipatova L.V. et al. Biological markers of the antiepileptic drugs efficacy and safety: pharmacogenetics and pharmacokinetics. Siberian Medical Review. 2017;(1):17–25. (in Russian). DOI: 10.20333/2500136-2017-1-17-25
17. Dmitrenko D.V., Strotskaya I.G., Artyukhov I.P. et al. Arrhythmogenic covulsive syncope in neurological practice: a case report. Int. J. Biomed. 2018;8(1):65–68. DOI: 10.21103/Article8(1)_CR1
18. Vernino S., Bourne K.M., Stiles L.E. et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019. National Institutes of Health expert consensus meeting — part 1. Auton. Neurosci. 2021;235. DOI: 10.1016/j.autneu.2021.102828
19. Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management (review). J. Intern. Med. 2019;285(4):352–366. DOI: 10.1111/joim.12852
20. Boris J.R. Postural orthostatic tachycardia syndrome in children and adolescents. Auton. Neurosci. 2018;215:97–101. DOI: 10.1016/j.autneu.2018.05.004
21. Boris J.R., Huang J., Bernadzikowski T. Orthostatic heart rate does not predict symptomatic burden in pediatric patients with chronic orthostatic intolerance. Clin. Auton. Res. 2020;30(1):19–28.; DOI: 10.1007/s10286-019-00622-y
22. Chelimsky G., Chelimsky T. The gastrointestinal symptoms present in patients with postural tachycardia syndrome: a review of the literature and overview of treatment. Auton. Neurosci. 2018;215:70–77. DOI: 10.1016/j.autneu.2018.09.003
23. Boris J.R., Bernadzikowski T. Demographics of a large paediatric Postural Orthostatic Tachycardia Syndrome Program. Cardiol. Young. 2018;28(5):668–674. DOI: 10.1017/S1047951117002888
24. Freeman R., Wieling W., Axelrod F.B. et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin. Auton. Res. 2011;21(2):69–72. DOI: 10.1007/s10286-011-0119-5
25. Brignole M., Moya A., de Lange F.J. et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur. Heart J. 2018;39(21):1883–1948. DOI: 10.1093/eurheartj/ehy037
Review
For citations:
Gvozdeva Yu.R., Kantimirova E.A., Dmitrenko D.V. Problems with the Diagnostics of Postural Orthostatic Tachycardia Syndrome. Case Studies. Title. 2023;22(2):26-31. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-2-26-31
Views:
19
Email this article 